Viridian Ria, LLC
- SEC CIK
- 0001730068
- Latest filing
- Apr 26, 2022
The latest 13F from Viridian Ria, LLC covers Q1 2022 (filed Apr 26, 2022): 81 long positions worth $430.2M. The top 10 holdings make up 64.8% of the portfolio, and the largest is Vanguard Ftse Developed Markets ETF at 11.2%. Livermore has 5 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q1 2022
Share counts compared with Q4 2021: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 1
- Est. +$19.8M
- Added
- 2
- Est. +$104.5K
- Reduced
- 75
- Est. −$729.1K
- Sold out
- 6
- Est. −$23.3M
Top 5 holdings
Share of this quarter's portfolio value
- Vanguard Ftse Developed Markets ETF92194385811.2%$48.1M
- SPYSPDR S&P 500 ETF Trust
- iShares Core S&P Small Cap ETF4642878049.2%$39.4M
- Vanguard Morningstar Mid-Cap ETF9229086297.5%$32.3M
- Vanguard Ftse Emerging Markets ETF9220428585.7%$24.4M
Biggest buys
New and added positions, by estimated amount bought
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q1 2022, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $430.2M
- −$43.1M (−9.1%) vs. prior quarter
- Positions
- 81
- −5 vs. prior quarter
- Top 10 concentration
- 64.8%
- Top 10 as share of value
- Turnover
- 4.4%
- Q1 2022, one quarter
- Average holding period
- 2.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
5 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $473.3M (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q1 2022 | Apr 26, 2022 | 81 | $430.2M | Vanguard Ftse Developed Markets ETFSPYiShares Core S&P Small Cap ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Jan 14, 2022 | 86 | $473.3M | Vanguard Ftse Developed Markets ETFSPYiShares Core S&P Small Cap ETF | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 8, 2021 | 17 | $11.9M | AMZNGOOGLADBE | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 30, 2021 | 79 | $435.0M | Vanguard Ftse Developed Markets ETFiShares Core S&P Small Cap ETFSPY | vs. Q1 2021 | SEC |
| Q1 2021 | May 10, 2021 | 79 | $397.5M | Vanguard Ftse Developed Markets ETFiShares Core S&P Small Cap ETFSPY | – | SEC |